Center for Opioid Epidemiology and Policy (COEP), Department of Population Health, Grossman School of Medicine, New York University, New York, New York, USA.
Millennium Nucleus for the Evaluation and Analysis of Drug Policies (nDP), Santiago, Chile.
Addiction. 2024 Apr;119(4):753-765. doi: 10.1111/add.16412. Epub 2024 Jan 8.
Longitudinal studies have revealed that substance use treatment use is often recurrent among patients; the longitudinal patterns and characteristics of those treatment trajectories have received less attention, particularly in the global south. This study aimed to disentangle heterogeneity in treatment use among adult patients in Chile by identifying distinct treatment trajectory groups and factors associated with them.
National-level registry-based retrospective cohort.
Adults admitted to publicly funded substance use disorder treatment programs in Chile from November 2009 to November 2010 and followed for 9 years (n = 6266).
Monthly treatment use; type of treatment; ownership of the treatment center; discharge status; primary substance used; sociodemographic.
A seven-class treatment trajectory solution was chosen using latent class growth analysis. We identified three trajectory groups that did not recur and had different treatment lengths: Early discontinuation (32%), Less than a year in treatment (19.7%) and Year-long episode, without recurrence (12.3%). We also identified a mixed trajectory group that had a long first treatment or two treatment episodes with a brief time between treatments: Long first treatment, or immediate recurrence (6.3%), and three recurrent treatment trajectory groups: Recurrent and decreasing (14.2%), Early discontinuation with recurrence (9.9%) and Recurrent after long between treatments period (5.7%). Inpatient or outpatient high intensity (vs. outpatient low intensity) at first entry increased the odds of being in the longer one-episode groups compared with the Early discontinuation group. Women had increased odds of belonging to all the recurrent groups. Using cocaine paste (vs. alcohol) as a primary substance decreased the odds of belonging to long one-episode groups.
In Chile, people in publicly funded treatment for substance use disorder show seven distinct care trajectories: three groups with different treatment lengths and no recurring episodes, a mixed group with a long first treatment or two treatment episodes with a short between-treatment-episodes period and three recurrent treatment groups.
纵向研究表明,物质使用治疗在患者中经常反复出现;这些治疗轨迹的纵向模式和特征受到的关注较少,特别是在全球南方。本研究旨在通过确定不同的治疗轨迹组及其相关因素,来剖析智利成年患者治疗使用中的异质性。
国家级基于登记的回顾性队列研究。
2009 年 11 月至 2010 年 11 月期间在智利接受公共资助的物质使用障碍治疗计划的成年人,并随访 9 年(n=6266)。
每月治疗使用情况;治疗类型;治疗中心所有权;出院状况;主要使用物质;社会人口统计学。
使用潜在类别增长分析选择了七种治疗轨迹解决方案。我们确定了三个不复发且治疗时间不同的轨迹组:早期中断(32%)、不到一年的治疗(19.7%)和无复发的一年期发作(12.3%)。我们还确定了一个混合轨迹组,该组有一个长的首次治疗或两次治疗之间有短暂的治疗间隔:长的首次治疗或立即复发(6.3%),以及三个复发治疗轨迹组:复发且减少(14.2%)、早期中断伴复发(9.9%)和治疗间隔长后复发(5.7%)。首次就诊时的住院或门诊高强度(与门诊低强度相比)增加了与早期中断组相比处于较长单疗程组的可能性。女性属于所有复发组的可能性增加。作为主要物质使用可卡因糊(与酒精相比)降低了属于长单疗程组的可能性。
在智利,接受公共资助的物质使用障碍治疗的人有七种不同的治疗轨迹:三个组的治疗时间不同,没有复发,一个混合组的首次治疗时间较长,或者两个治疗发作之间的治疗间隔较短,以及三个复发治疗组。